Comparative Life Cycle Assessment of reusable and single-use specula used in Belgian hospitals
Sophie Huysveld1, Liesbet Demarré2, Katrien Vanderwee2, Simon Malfait2, Veerle Duprez2, Jo Dewulf1, Norbert Fraeyman2
1Sustainable Systems Engineering (STEN), Department of Green Chemistry and Technology, Faculty of Bioscience Engineering, Ghent University, Coupure Links 653, 9000 Ghent, Belgium; 2Ghent University Hospital, 9000 Ghent, Belgium
An LCA comparing healthcare facility-based haemodialysis with home haemo- and peritoneal dialysis in Australia
Scott McAlister1,2, Katherine Barraclough3
1The University of Melbourne, Australia; 2The University of Sydney, Australia; 3The Royal Melbourne Hospital, Australia
Life Cycle Assessment of phase I and phase III clinical trials
Rodrigo Alvarenga1, Jason LaRoche2, Annemie Chiau2, Thomas Costelloe3, Michael Collins3, Simon Aumônier4
1ERM, Belgium; 2Janssen Clinical Innovation (JCI); 3ERM, United Kingdom; 4Aumônier Consulting Limited
The Application of LCA in Healthcare Using the Care Pathway Approach
Aoife Calnan1, Nigel Budgen2, Thomas Costelloe1, Rodrigo Alvarenga1, Michael Collins1
1ERM; 2AstraZeneca
Calculation of Scope 3 GHG emissions of purchased goods and services applying a hybrid approach based on life cycle thinking
Aoife Calnan1, Saori Galley1, Amelia Nunn2, Simon Aumônier3
1ERM; 2Becton Dickinson; 3Aumônier Consulting
A Collaborative Approach towards Product Category Rules for Pharmaceuticals
Isolda Agustí-Juan1, Sarah Arias-Zeballos2, Wouter De Soete3, Trine Lund Neidel4, Sarah Mandlebaum5, Barry Dillon6, Oliver Schwab7, Andy Whiting8
1Roche Diagnostics International AG; 2Sanofi Winthrop Industrie; 3Janssen Pharmaceutica NV; 4Novo Nordisk; 5Takeda Pharmaceutical Company Limited; 6Pfizer; 7GSK plc; 8AstraZeneca UK Limited
|